Annual Drug Patent Expirations for SUTENT
Sutent is a drug marketed by Cppi Cv and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in SUTENT is sunitinib malate. Two suppliers are listed for this compound. Additional details are available on the sunitinib malate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com